Home » STELLAR PHARMACEUTICALS INC. SIGNS LICENSING AGREEMENT FOR URACYST'R' IN CHINA
STELLAR PHARMACEUTICALS INC. SIGNS LICENSING AGREEMENT FOR URACYST'R' IN CHINA
Stellar Pharmaceuticals Inc. a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that it has signed a licensing agreement with Shanghai Ya Jun Medical Equipment Co. Ltd. ("Shanghai Ya Jun Medical Equipment") for the sale of Uracyst(R) in China. Uracyst is a patented therapeutic used in the treatment of glycosaminoglycan (GAG) deficient cystitis, such as Interstitial Cystitis ("IC"), Radiation Induced Cystitis and Chronically Recurring Cystitis.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1067858XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May